2001
DOI: 10.1097/00003226-200104000-00008
|View full text |Cite
|
Sign up to set email alerts
|

Human Immunodeficiency Virus p24 Antigen Testing in Cornea Donors

Abstract: Results from p24 assays by other tissue banks may cause difficult clinical situations when the results are received after transplantation of the tissue, but the use of the p24 assay in the screening of cornea donors may result in excessive waste of donor tissue. Further guidance is needed regarding the management of positive results from this and other nonrequired screening tests.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
4
0

Year Published

2002
2002
2022
2022

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 8 publications
(4 citation statements)
references
References 17 publications
0
4
0
Order By: Relevance
“…False-reactive virological results had been reported for donor samples taken post mortem. [ 22 ] Avoiding false-reactive virological results is an important factor in current cornea graft scarcity. [ 4 , 5 ]…”
Section: Discussionmentioning
confidence: 99%
“…False-reactive virological results had been reported for donor samples taken post mortem. [ 22 ] Avoiding false-reactive virological results is an important factor in current cornea graft scarcity. [ 4 , 5 ]…”
Section: Discussionmentioning
confidence: 99%
“…However, there is generally only limited scope for improvement in this area. Over the years the criticality of sample quality has been highlighted by others with issues such as haemolysis, haemodilution and volume identified [9–13]. NHSBT has spent time looking at the training of its retrieval teams in relation to obtaining optimal blood samples, but these may be collected separately to the tissue retrieval, and by local staff.…”
Section: Discussionmentioning
confidence: 99%
“…Although p24 testing of cornea donors has not been recommended as mandatory, many tissue banks using other organs from cornea donors do perform this assay and the US FDA requires that eye banks reject corneal tissue if a reactive p24 assay is reported. The use of the p24 assay in the screening of cornea donors may result in excessive waste of donor tissue [28] but adoption of HIV p24 antigen testing may be considered as part of serology testing in developing nations where HIV infections have been on a steady rise in the recent years.…”
Section: Selection Of Donor Corneamentioning
confidence: 99%